Nations

This archive collects milestones and progress stories involving nations — countries and their governments — acting to improve lives, protect rights, or address shared challenges. From policy breakthroughs to international cooperation, these stories show what countries are doing right.

Industrial pipes and infrastructure at a coastal energy facility for an article about carbon capture and storage, for article on fusion plasma record, for article on fusion plasma record, for article on fusion endurance record, for article on nuclear fusion ignition

American scientists repeatedly produce nuclear fusion ignition for the first time in history

Nuclear fusion just cleared a crucial bar: scientists at California’s Lawrence Livermore National Laboratory have now achieved ignition four separate times, with the best shot producing 89 percent more energy than the lasers delivered to the target. That repetition is what transforms a single 2022 breakthrough into real, replicable science — proof that the Sun-like reaction can be coaxed out of a frozen hydrogen pellet on Earth, again and again. Momentum is building beyond the lab, too, with more than $6 billion now invested in fusion worldwide and governments at COP28 agreeing to speed things along. The road from a boiled kettle’s worth of energy to a clean-powered grid is still long, but the hardest physics is finally behind us.

Uruguayan flag, for article on Uruguay renewable electricity

Uruguay now generates more than 90% of its electricity from renewables

Uruguay now generates between 90% and 98% of its electricity from renewables, a shift it pulled off in roughly 15 years after starting out almost entirely dependent on imported oil. The turning point came in 2008, when an oil price spike pushed the government to take a chance on a nuclear physicist with an unconventional pitch: skip the nuclear plant, go all in on wind. About 50 wind farms later, paired with existing hydropower, the country had one of the cleanest grids on Earth — and around 50,000 new jobs in a nation of just 3.4 million. Uruguay’s quiet experiment offers something the global energy transition badly needs: proof that a small country, starting from scratch, can actually do this.

Car exhaust|Traffic on a bridge

Canada to end sales of gas-powered cars by 2035

Under the new rules, electric or hydrogen-powered cars will account for 20% of new sales by 2026, 60% by 2030, and 100% by 2035. The rules mirror similar 2035 phase-out mandates in China, South Korea, the U.K. and several U.S. states, including California, New York, and Massachusetts.

Break Free From Fossil Fuels flyer

Australia and Norway to stop overseas fossil fuel financing

Australia and Norway have formally joined the Clean Energy Transition Partnership (CETP), a historic alliance aiming at ending international public subsidies for fossil fuels. The CETP was launched during COP26 in Glasgow and has grown to include 41 countries and organizations, signaling a significant step forward in combating the climate catastrophe.

Waving a pride flag

Thailand to legalize same-sex marriage

The Southeast Asian country will become the third Asian nation, after Taiwan and Nepal, to legalize same-sex marriage. A new amendment to its Civil and Commercial Code will change the words “men and women” and “husband and wife” to “individuals” and “marriage partners.” The next step will be an amendment to the country’s pension fund law to recognize same-sex couples.

Pills spilling out of pill bottle, for article on march-in rights policy

U.S. sets policy to seize patents of government-funded drugs if price deemed too high

Drug patent seizures are back on the table for the first time in over 40 years, with the Biden administration releasing a draft roadmap that explicitly lets the federal government license out medicines to competitors when companies charge prices most Americans can’t afford. The power has existed since 1980 but was never used or even defined — until now. Price itself is now a factor: if a drug was built on taxpayer-funded research through agencies like the NIH, and the company sells it out of reach of ordinary patients, generics could be authorized. Even as a credible threat, this reframes who publicly funded science is really for — and could shift drug pricing fights well beyond U.S. borders.